Cholesterol-related health issues are a pressing concern across the United States, disproportionately affecting certain communities. While medical research strives to develop effective medications, a critical gap remains: the underrepresentation of LatinX and Black Americans in clinical trials. This blog post delves into the reasons behind this disparity, the profound importance of diverse participation, and the potential for groundbreaking medical advancements that could result from greater inclusion.

Diabetes is a global health crisis, and its impact is particularly severe in communities of color. LatinX and Asian American populations are disproportionately affected by this chronic disease, yet they remain underrepresented in clinical trials for new diabetes drugs. This lack of diversity in research has serious consequences, hindering the development of treatments that are truly effective and safe for all.